| Date | Form | Description | Docs | XBRL | Pages |
| 03/10/10 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
8 | |
| 03/10/10 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
80 | |
| 02/23/10 | UPLOAD | SEC-generated letter |
|
5 | |
| 01/29/10 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
121 | |
| 12/11/09 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/11/09 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/30/09 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/13/09 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/13/09 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/23/09 | DEF 14A | Definitive proxy statements |
|
20 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read More...Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
Read More...Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Read More...